Nakul Singh, MD, MS
Born in London, England and raised in Cleveland, OH, Dr. Nakul Singh earned his BS in Biology from the University of Chicago, followed by his MS in Biostatistics from Harvard T.H. Chan School of Public Health (HSPH), where he received the Glickenhaus Fund and Snitzler scholarships. During that time, he performed ophthalmology-related research as a research fellow at LV Prasad Eye Institute in Hyderabad, India, for which he received a travel grant from the Harvard Department of Biostatistics to estimate prevalence, risk factors, and causes of blindness in three tribal areas of Andhra Pradesh. He also completed his master’s thesis entitled, “Inferring an evolutionary tree of uveal melanoma,” which identified key mutations driving cancer development and new possible subtype of uveal melanoma defined by unique mutation and rates of metastasis. He went on to earn his MD from Case Western Reserve University School of Medicine. During medical school, he worked as a Research Associate in the Cleveland Clinic Department of Ophthalmology measuring the relationship between pharmaceutical payments in promotion of anti-VEGF agents and anti-VEGF agent use among ophthalmologists in the United States. Dr. Singh has presented his research at conferences such as the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the International Society of Ocular Oncology, and the Pan-American Congress of Ophthalmology. He has published book chapters, as well as articles in journals such as the American Journal of Ophthalmology, JAMA Ophthalmology, Ophthalmology, and PLoS One.